Hetero bags DCG(I) approval for generic version of ‘Daclatasvir’ Sanjiv Das Dec 14, 2015 The product in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections Hetero has…
Hetero receives DCG(I) approval for fixed-dose combination therapy ‘Ledipasvir-Sofosbuvir’ Usha Sharma Dec 8, 2015 The product will be available under the brand name ‘Ledisof’ in India
